Scott Braunstein Marinus Pharmaceuticals, Inc. (MRNS) insider trading activity

Scott Braunstein is CHAIRMAN AND CEO of MARINUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 298,667 shares of MRNS, which is worth approximately $98,560. The most recent transaction as insider was on Aug 05, 2024, when has been sold 12,145 shares (Common Stock) at a price of $1.13 per share, resulting in proceeds of $13,723. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 299K

3.91% 3M change

85.78% 12M change

Total Value Held $98,560

Scott Braunstein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 05 2024	SELL Open market or private sale	$13,723 $1.13 p/Share	12,145 Reduced 3.91%	298,667 Common Stock
Jun 18 2024	BUY Grant, award, or other acquisition	-	37,300 Added 10.71%	310,812 Common Stock
Mar 27 2024	BUY Exercise of conversion of derivative security	$214,000 $4.28 p/Share	50,000 Added 15.46%	273,512 Common Stock
Feb 16 2024	SELL Open market or private sale	$117,789 $9.94 p/Share	11,850 Reduced 5.03%	223,512 Common Stock
Jan 18 2024	BUY Grant, award, or other acquisition	-	74,600 Added 24.07%	235,362 Common Stock
Aug 08 2023	SELL Open market or private sale	$268 $8.94 p/Share	30 Reduced 0.02%	160,762 Common Stock
Aug 07 2023	SELL Open market or private sale	$61,244 $9.55 p/Share	6,413 Reduced 3.84%	160,792 Common Stock
Jan 26 2023	BUY Grant, award, or other acquisition	-	80,000 Added 32.36%	167,205 Common Stock
May 24 2022	BUY Grant, award, or other acquisition	-	19,305 Added 18.13%	87,205 Common Stock
Feb 04 2022	BUY Grant, award, or other acquisition	-	42,900 Added 38.72%	67,900 Common Stock

Also insider at

TRVN

TREVENA INC Healthcare

Director

CNST

CONSTELLATION PHARMACEUTICALS INC Healthcare

CRBU

Caribou Biosciences, Inc. Healthcare

Director

ATAI

ATAI Life Sciences N.V. Healthcare